Testing effectiveness (Phase 2)Study completedNCT02400788
What this trial is testing
Resminostat (YHI-1001) in Combination With Sorafenib in Asian Patients With Advanced Hepatocellular Carcinoma (HCC)
Who this might be right for
Hepatocellular Carcinoma
Yakult Honsha Co., LTD 179